Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

121.93 +2.18 (+1.82%)

Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	13,083,323
Open	120.76
Bid (Size)	121.56 (100)
Ask (Size)	122.50 (100)
Prev. Close	119.75
Today's Range	120.44 - 122.66
52wk Range	73.31 - 122.66
Shares Outstanding	2,531,374,696
Dividend Yield	2.79%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AstraZeneca’s Strategic Takeover of Modella AI Signals the Rise of Agentic Oncology

February 06, 2026

In a move that underscores the pharmaceutical industry’s aggressive pivot toward integrated artificial intelligence, AstraZeneca (NASDAQ: AZN) recently announced the full acquisition of Modella AI, a...

Via TokenRing AI

Fiscal Brinkmanship: Data Blackout and the DHS Cliff Loom Over Markets After Narrow Funding Deal

February 06, 2026

In a week defined by high-stakes political theater and a brief but disruptive lapse in federal operations, Washington has managed to pull back from the edge of a total collapse—though only partially....

Via MarketMinute

Performance

YTD	+14.5%	+14.5%
1 Month	+12.3%	+12.3%
3 Month	+41.3%	+41.3%
6 Month	+51.1%	+51.1%
1 Year	+38.5%	+38.5%

More News

Merck & Co. Inc. (NYSE:MRK) Beats Q4 Estimates but 2026 Outlook Cautions Investors ↗

February 03, 2026

Via Chartmill

Technical Breakout Setup for Merck & Co. Inc. (NYSE:MRK) ↗

January 31, 2026

Via Chartmill

The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff

February 06, 2026

Via MarketMinute

The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance

February 06, 2026

Via Finterra

Trump Administration To Launch TrumpRx Platform For Discounted Drugs Later On Thursday: Reports ↗

February 05, 2026

Via Stocktwits

USDA Unveils $100 Million 'Grand Challenge' to Thwart Flesh-Eating Screwworm as Threat Reaches U.S. Border

February 05, 2026

Via MarketMinute

AI Panic Hits Software, PayPal Faceplants, Walmart Joins the $1T Club ↗

February 04, 2026

Via Chartmill

How Merck Is Preparing For The Patent Cliff Of Its Blockbuster Cancer Drug Keytruda ↗

February 04, 2026

Via Stocktwits

MRK Q4 Deep Dive: Pipeline Expansion and New Product Launches Shape Guidance

February 04, 2026

Via StockStory

Merck (MRK) Q4 2025 Earnings Call Transcript ↗

February 03, 2026

Via The Motley Fool

Merck’s (NYSE:MRK) Q4 CY2025 Sales Beat Estimates

February 03, 2026

Via StockStory

Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline

February 03, 2026

From Merck & Co., Inc.

Via Business Wire

The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs

February 02, 2026

Via MarketMinute

The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate

February 02, 2026

Via MarketMinute

Merck (MRK) Q4 Earnings Report Preview: What To Look For

February 01, 2026

Via StockStory

Should You Buy Guardant Health Before Feb. 19? ↗

January 30, 2026

Via The Motley Fool

2 Cash-Producing Stocks to Target This Week and 1 We Ignore

January 28, 2026

Via StockStory

This Stock Is Already Up 58% This Year. Is It a Buy? ↗

January 28, 2026

Via The Motley Fool

Constitutional Cliffhanger: Supreme Court Set to Rule on Executive Tariff Power as Market Braces for Margin Volatility

January 28, 2026

Via MarketMinute

The $4 Billion Avatar: How Synthesia is Defining the Era of Agentic Enterprise Media

January 28, 2026

Via TokenRing AI

FDA Codifies AI’s Role in Drug Production: New 2026 Guidelines Set Global Standard for Pharma Safety and Efficiency

January 28, 2026

Via TokenRing AI

Merck Announces Second-Quarter 2026 Dividend

January 27, 2026

From Merck & Co., Inc.

Via Business Wire

2 Pharmaceutical Stocks Set to Rebound in 2026 ↗

January 27, 2026

Via The Motley Fool

Frequently Asked Questions

Is Merck & Co publicly traded?

Yes, Merck & Co is publicly traded.

What exchange does Merck & Co trade on?

Merck & Co trades on the New York Stock Exchange

What is the ticker symbol for Merck & Co?

The ticker symbol for Merck & Co is MRK on the New York Stock Exchange

What is the current price of Merck & Co?

The current price of Merck & Co is 121.93

When was Merck & Co last traded?

The last trade of Merck & Co was at 02/06/26 07:00 PM ET

What is the market capitalization of Merck & Co?

The market capitalization of Merck & Co is 308.65B

How many shares of Merck & Co are outstanding?

Merck & Co has 309B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.